It is a pleasure to announce that our new Centre Director for UK DRI at King’s is Prof Jernej Ule, an expert in RNA biology and its role in neurodegenerative diseases such as Amyotrophic lateral sclerosis (ALS).
Prof Jernej Ule (pronounced “Yernay Yulay”) will lead the UK DRI at King’s from April 2022, in addition to taking up the position of van Geest Professor of Neurodegeneration Research. His responsibilities include providing scientific leadership within the UK DRI community, developing collaborative opportunities at King’s as well as across the wider neurodegeneration community and industry, and contributing to the growth and success of the Institute.
On the announcement, Prof Jernej Ule, said:
“I’m thrilled to join the UK DRI, an institute which offers a unique multi-centre environment bringing together so many bright minds from diverse fields. This is the best way to make progress in understanding and treating dementia. My vision for the UK DRI Centre at King’s is to enhance its interdisciplinary approaches, and capacity to take molecular insights towards the clinic through innovative gene therapy technologies."